Research and Development

Showing 15 posts of 9573 posts found.

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017 Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …
lilly2_web

Lilly looks to leave behind animal health business

October 25, 2017 Research and Development, Sales and Marketing Elanco, Eli Lilly, biotech, drugs, pharma, pharmaceutical

Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …

GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost

October 25, 2017 Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …
8384110298_da510e0347_c

Research finds blood-thinners protect against dementia

October 25, 2017 Research and Development Alzheimer's, anticoagulant, biotech, dementia, drugs, pharma, pharmaceutical

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …
diabetes-2424105_960_720

Type 3 diabetes more common than Type 1 and often misdiagnosed

October 25, 2017 Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …
alessandro-riva

Gilead promotes Alessandro Riva to Senior VP, Hematology and Oncology Therapeutic Area Head

October 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …
shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

October 24, 2017 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

Recipharm equips Lisbon facility for US and European serialisation

October 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …
lauritzen1_k100

Securing the cold chain with new solutions

October 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cold chain, manufacturing, supply chain

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Another week gone, and it’s deadline day here at Pharmafocus, meaning you can look forward to our November issue next …
dna-1903319_960_720

Small number of mutations driving most cancers

October 20, 2017 Medical Communications, Research and Development Cancer, biotech, drugs, pharma, pharmaceutical

Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are …
celgene_building

Celgene drops $710m drug, shares nosedive 7%

October 20, 2017 Medical Communications, Research and Development Celgene, biotech, drugs, pharma, pharmaceutical

Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely …
portraits-1474_approved_cut

Access to Innovation: Beyond a ‘pharma-only’ approach

October 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ecco, oncology

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most …
lilly_entrance_web

Lilly teams up with CureVac in $1.8 billion cancer vaccine partnership

October 19, 2017 Research and Development, Sales and Marketing Cancer, CureVac, Eli Lilly, Vaccine

Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to …
The Gateway to Local Adoption Series

Latest content